Acetone is a pharmaceutical manufacturing solvent whose permitted daily exposure in drug products is defined by ICH Q3C based on a critical repeat-dose toxicological study. The concentration limit for Acetone in drug substances is derived by dividing the PDE by the maximum administered dose per day. Analytical method development for residual Acetone quantification typically employs headspace GC-FID or GC-MS, with the method validated to demonstrate linearity, accuracy, precision, and sensitivity at levels corresponding to the applicable concentration limit. Occupational inhalation exposure to Acetone vapour during manufacturing operations is assessed against established OEL values.
ICH Q3A qualification thresholds for impurities in new drug substances require toxicological qualification of individual impurities of Acetone exceeding the reporting threshold (0.05% or 1 mg TDI, whichever is lower), identification threshold (0.10% or 2 mg TDI), and qualification threshold (0.15% or 2 mg TDI).
